Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.4825
H.R.4825: MEDS Act
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced Jan. 18, 2018
- Latest Major Action Jan. 24, 2018
Bill Sponsor
Bill Cosponsors
15 (9 Democrats, 6 Republicans)
Bill Version
- Introduced in House - Jan. 18, 2018
Bill Summary
Marijuana Effective Drug Studies Act of 2018 or the MEDS Act This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research involving marijuana and the commercial production of drugs made from marijuana. Specifically, the bill requires the Drug Enforcement Administration to register manufacturers and distributors to supply marijuana: (1) for use in research, and (2) for the commercial...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
Jan. 24, 2018 |
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
|
Jan. 19, 2018 |
Referred to the Subcommittee on Health.
|
Jan. 18, 2018 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
Jan. 18, 2018 |
Introduced in the House by Rob Bishop (R-Utah) |